Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2026-01-01 @ 8:17 PM
Study NCT ID:
NCT01611558
Status:
COMPLETED
Last Update Posted:
2020-07-13
First Post:
2012-05-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Study of Ipilimumab Monotherapy in Recurrent Platinum-sensitive Ovarian Cancer
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-08-21
Start Date Type:
ACTUAL
Primary Completion Date:
2014-11-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-07-03
Completion Date Type:
ACTUAL
First Submit Date:
2012-05-25
First Submit QC Date:
None
Study First Post Date:
2012-06-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-03-07
Results First Submit QC Date:
None
Results First Post Date:
2016-04-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-09
Last Update Post Date:
2020-07-13
Last Update Post Date Type:
ACTUAL